ibogaine has been researched along with 1-anilino-8-naphthalenesulfonate in 1 studies
| Studies (ibogaine) | Trials (ibogaine) | Recent Studies (post-2010) (ibogaine) | Studies (1-anilino-8-naphthalenesulfonate) | Trials (1-anilino-8-naphthalenesulfonate) | Recent Studies (post-2010) (1-anilino-8-naphthalenesulfonate) |
|---|---|---|---|---|---|
| 445 | 8 | 136 | 24,275 | 480 | 7,815 |
| Protein | Taxonomy | ibogaine (IC50) | 1-anilino-8-naphthalenesulfonate (IC50) |
|---|---|---|---|
| Chain A, RNA-directed RNA polymerase NS5 | Dengue virus 2 16681-PDK53 | 100 | |
| Mitogen-activated protein kinase 14 | Homo sapiens (human) | 1.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dimitrova, P; Falcocchio, S; Ivanovska, N; Patkar, S; Saso, L; Xoxi, E; Yordanov, M | 1 |
1 other study(ies) available for ibogaine and 1-anilino-8-naphthalenesulfonate
| Article | Year |
|---|---|
Ibogaine reduces organ colonization in murine systemic and gastrointestinal Candida albicans infections.
Topics: Adhesiveness; Amphotericin B; Animals; Antifungal Agents; Brain; Candida albicans; Candidiasis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Gastrointestinal Diseases; Hypersensitivity, Delayed; Ibogaine; Injections, Intraperitoneal; Kidney; Lipase; Liver; Male; Mice; Mice, Inbred BALB C; Spleen | 2005 |